The Novo-backed musculoskeletal disease therapy developer's market capitalisation stood at $1.6bn as of close of trading yesterday.

The Amazon-backed food delivery service raised $2.07bn in its initial public offering only to see its shares fall some 25% on its opening day.

The online learning platform developer spun out of Stanford University priced its shares at the top of their range.

Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

The Seek Group, Laureate Education and BCC-backed online learning platform developer priced its shares at the top of their range.

SoftBank’s SB Management subsidiary, Illumina and Novartis are backing a $375m PIPE supporting the deal, which values the proteomics technology provider at $1.23bn.

Ingka Group-backed vertical farm operator Aerofarms is joining forces with a special purpose acquisition company at a $1.2bn post-transaction valuation.

UK-based biopharmaceutical company raises $75m in IPO

NeuroPace to raise $75m on Nasdaq.

The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.